Advertisement
Drug Information Association Logo
Corporate Tagline

Meetings & Training

DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations.

Find Meetings & Training 

Name Start Date Credits Format Region Location
Clinical Investigator: Module 2 - Conducting The Study Apr 21, 2014 ACPE, CME Online Instruction North America Online
Clinical Investigator: Module 1 - Study Preparation and Initiation Apr 21, 2014 ACPE, CME Online Instruction North America Online
Informed Consent Apr 21, 2014 ACPE Online Instruction North America Online
Crisis Management Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Database Management Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Literature Evaluation Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Literature Searching Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Medical Inquiries Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Medical Writing Apr 21, 2014 IACET Online Instruction North America Online
Product Labeling Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Regulatory Issues Apr 21, 2014 ACPE, IACET Online Instruction North America Online
Statistics for Medical Communications Professionals Apr 21, 2014 ACPE, IACET Online Instruction North America Online
The Use of Mobile Medical Applications as Companions Apr 21, 2014 Online Instruction Global Online
Regulating a Social World Apr 21, 2014 Online Instruction Global Online
English Literacy and Spanish Transcreation of Patient Documents: Concepts for Low Literacy Materials Apr 21, 2014 Online Instruction Global Online
Emerging Technologies to Rare Disorder Drug Development: Promises and Pitfalls Apr 21, 2014 Online Instruction Global Online
Implementation of the FDASIA Patient Provisions Apr 21, 2014 Online Instruction Global Online
Safety and Social Media: Is this the Question or the Answer Apr 21, 2014 Online Instruction Global Online
Complimentary Patient-Centeredness and Engagement in Clinical Research: Opportunities for Industry Apr 21, 2014 Online Instruction Global Online
Aligning the Voices of Change in the Health Care System Apr 21, 2014 Online Instruction Global Online
Negotiation and Influence Apr 21, 2014 Online Instruction Global Online
Evaluation and Management of Cardiac Conditions in Oncology Patients Apr 21, 2014 Online Instruction Global Online
Risk Management of Medicinal Products: REMS and RMP - Need for Harmonization Within the ICH Region? Apr 21, 2014 Online Instruction Global Online
A Closer Look at FDASIA Provisions to Promote Biomedical Innovation Apr 21, 2014 Online Instruction Global Online
CDER Town Meeting: Safety Hot Topics Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series - Part 1: Introduction to the Benefit-Risk - Why is Everyone Talking about Benefit-Risk? Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series Part 2 - Benefit-Risk Assessment a Changing Regulatory Landscape Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series - Part 3: Framing for Benefit-Risk Assessment and Communication Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series - Part 4: Clinical Judgment and Pragmatic Considerations for Endpoint Selection and Display in Benefit-Risk Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series- Part 5: Stated Choice Methods for Valuing Benefits and Risks Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series-Part 6: Multi-criteria Decision Analysis to Assist in the Decision Making Process Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series- Part 7: A Structured, Quantitative Health Outcomes Approach to Drug Benefit-Risk Analysis Apr 21, 2014 Online Instruction Global Online
Assessing the Benefits and Risks of Medicines: Webinar Series- Part 8: Visualization and Communication of Benefit-Risk Apr 21, 2014 Online Instruction Global Online
Practical Aspects and Examples of Using Large Datasets for Investigating Product Safety and Effectiveness in the US and EU Apr 21, 2014 Online Instruction Global Online
New Good Pharmacovigilance Practice (GVP) Documents in Canada Apr 21, 2014 Online Instruction Global Online
Clinical Statistics for Nonstatisticians Apr 21, 2014 Online Instruction Global Online
Development of a Clinical Study Report Apr 21, 2014 Online Instruction Global Online
Complimentary Biomarker Strategies for More Efficient Early-Phase Drug Development in Alzheimer's Disease Apr 21, 2014 Online Instruction Global Online
Using Patient-Reported Outcomes to Assess Product Safety and Tolerability: Methodological and Regulatory Considerations Apr 21, 2014 Online Instruction Global Online
CardioVascular Safety: The New Paradigm - Proarrhythmic Assessment of New Drugs without the Thorough QT Study Apr 21, 2014 Online Instruction Global Online
CardioVascular Safety – What are the Key Issues Regarding Blood Pressure Assessment During Clinical Development Apr 21, 2014 Online Instruction Global Online
Electronic Submissions 101 – Essential MS Word and Adobe Acrobat Tools/Skills and Current IT Options Apr 21, 2014 Online Instruction Global Online
EDM and ERS/eCTD: Impact of e-Initiatives on Content and Context: FDA Update/Progress Report Apr 21, 2014 Online Instruction Global Online
Regulatory and Legal Landscape Impacting Medical and Scientific Communications Apr 21, 2014 Online Instruction Global Online
A Tour of FDA Apr 21, 2014 Online Instruction Global Online
A Tour of Health Canada Apr 21, 2014 Online Instruction Global Online
A Tour of Health Europe Apr 21, 2014 Online Instruction Global Online
Aspects of Regulatory History Apr 21, 2014 Online Instruction Global Online
Bioresearch Monitoring Program (BIMO): Introduction Apr 21, 2014 Online Instruction Global Online
The Clinical Development Process: Investigational Product, Plan, and Data Management Apr 21, 2014 Online Instruction Global Online
Drug Safety & Adverse Event Reporting Apr 21, 2014 Online Instruction Global Online
Ethical Review Boards Apr 21, 2014 Online Instruction Global Online
Ethics as the Foundation to Clinical Research Apr 21, 2014 Online Instruction Global Online
Awareness of FDA Inspections for Pharmaceutical Manufacturers Apr 21, 2014 Online Instruction Global Online
Biotechnology: An Overview of Compliance Considerations Apr 21, 2014 Online Instruction Global Online
Change Control Apr 21, 2014 Online Instruction Global Online
Clinical Trial Audits and Consequences of Non-Compliance Apr 21, 2014 Online Instruction Global Online
Computerized Systems Inspections in the Medical Device Industry Apr 21, 2014 Online Instruction Global Online
European Union Clinical Trials Directive Apr 21, 2014 Online Instruction Global Online
GMP Principals of SOPs Apr 21, 2014 Online Instruction Global Online
GMP Updates - Enforcement Changes at the New FDA Apr 21, 2014 Online Instruction Global Online
GMPs for API Bulk Manufacturers Apr 21, 2014 Online Instruction Global Online
Good Clinical Practices (GCPs) for New Product Investigations Apr 21, 2014 Online Instruction Global Online
Good Laboratory Practices (GLPs) Apr 21, 2014 Online Instruction Global Online
GxPs Apr 21, 2014 Online Instruction Global Online
HIPAA - The Impact on Clinical Research Apr 21, 2014 Online Instruction Global Online
Introduction to GMPs Apr 21, 2014 Online Instruction Global Online
Investigational Product Development Apr 21, 2014 Online Instruction Global Online
ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Apr 21, 2014 Online Instruction Global Online
Key Concepts of Process Validation Apr 21, 2014 Online Instruction Global Online
Laboratory Specimens for Clinical Research Apr 21, 2014 Online Instruction Global Online
Medical Device Safety Reporting Apr 21, 2014 Online Instruction Global Online
Orientation to GMP Compliance Apr 21, 2014 Online Instruction Global Online
Overview of the Clinical Research Process Apr 21, 2014 Online Instruction Global Online
Part 11: Electronic Records and Signatures - Application Apr 21, 2014 Online Instruction Global Online
Part 11: Electronic Records; Electronic Signatures Apr 21, 2014 Online Instruction Global Online
Principles of Good Documentation Apr 21, 2014 Online Instruction Global Online
Protection of Human Subjects in Clinical Trials Apr 21, 2014 Online Instruction Global Online
Selecting and Managing Clinical Contract Research Organizations (CROs) Apr 21, 2014 Online Instruction Global Online
Understanding Post-Approval Changes Apr 21, 2014 Online Instruction Global Online
Computerized Systems Inspections in the Pharmaceutical Industry Apr 21, 2014 Online Instruction Global Online
Basics of the PhRMA Code Apr 21, 2014 Online Instruction Global Online
Basics of AdvaMed Code Apr 21, 2014 Online Instruction Global Online
Eucomed Guidelines on Interactions with Healthcare Professionals Apr 21, 2014 Online Instruction Global Online
Introduction to Medical Device Health Care Compliance Apr 21, 2014 Online Instruction Global Online
Foreign Corrupt Practices Act Apr 21, 2014 Online Instruction Global Online
Global Anti-bribery Apr 21, 2014 Online Instruction Global Online
Variations to Marketing Authorisation in Europe Apr 21, 2014 Online Instruction Global Online
Registration of Monoclonal Antibodies Apr 21, 2014 Online Instruction Global Online
How to Gain Approval to Market a Generic Medicinal Product in the USA Apr 21, 2014 Online Instruction Global Online
Pharmacokinetics and Pharmacodynamics in Drug Registration Apr 21, 2014 Online Instruction Global Online
Measurement in Clinical Trials: An Examination of the FDA Position on Review of Clinical Outcome Assessments (COAs) Apr 21, 2014 Online Instruction Global Online
The Electronic Trial Master File: So Much More than Just a Secure Document Repository Apr 21, 2014 Online Instruction Global Online
Planning and Implementing Large Cardiovascular Outcomes Studies: Opportunities & Challenges Apr 21, 2014 Online Instruction Global Online
Press the Easy Button – Ensure Consistency and Compliance for your Documents through Automation Apr 21, 2014 Online Instruction Global Online
When Outsourcing Stops Making Sense Apr 21, 2014 Online Instruction Global Online
Complimentary Quintiles/DIA Webinar - Giving Your Study The Right Start Toward Success Through Optimal Country and Site Selection Apr 21, 2014 Online Instruction Global Online
Fundamentals of Project Management for Nonproject Managers Apr 21, 2014 Online Instruction Global Online
Planning and Managing Your Project Apr 21, 2014 Online Instruction Global Online
Change Management, Issues Management, Escalation Management Apr 21, 2014 Online Instruction Global Online
Preparing a Clinical Trial Budget Apr 21, 2014 Online Instruction Global Online
Project Risk Management: Dealing with the Certainty of Uncertainty Apr 21, 2014 Online Instruction Global Online
Team Building and Development Apr 21, 2014 Online Instruction Global Online
Drug & Cosmetic Rule Amendments: Changes in Regulations Governing Clinical Trials in India Apr 21, 2014 Online Instruction Global Online
Introduction to the European Union Institutions and Regulatory Authority Apr 21, 2014 Online Instruction Global Online
Introduction to US Institutions and Regulatory Authority (FDA) Apr 21, 2014 Online Instruction Global Online
Introduction to Japanese Institutions and Regulatory Authorities Apr 21, 2014 Online Instruction Global Online
Overview of the CTD and eCTD Apr 21, 2014 Online Instruction Global Online
Introduction to the International Conference on Harmonisation (ICH) Apr 21, 2014 Online Instruction Global Online
The Regulatory Development of a Drug Apr 21, 2014 Online Instruction Global Online
Basics of Clinical Trials Apr 21, 2014 Online Instruction Global Online
How to Register Medicinal Products through the Centralized Procedure Apr 21, 2014 Online Instruction Global Online
How to Register Medicinal Products through the Mutual Recognition Procedure Apr 21, 2014 Online Instruction Global Online
How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Apr 21, 2014 Online Instruction Global Online
How to Register a New Drug in the USA Apr 21, 2014 Online Instruction Global Online
How to Register Medicinal Products through the Decentralized Procedure Apr 21, 2014 Online Instruction Global Online
Access to Unapproved Drugs through Compassionate Use Apr 21, 2014 Online Instruction Global Online
Regulatory Requirements for the Conduct of Clinical Trials in Europe Apr 21, 2014 Online Instruction Global Online
Orphan Drugs in the USA, European Union, and Japan Apr 21, 2014 Online Instruction Global Online
Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Apr 21, 2014 Online Instruction Global Online
Meeting Opportunities with Regulatory Agencies Apr 21, 2014 Online Instruction Global Online
A Regulatory Perspective of Biosimilars in Emerging Markets Apr 21, 2014 Online Instruction Global Online
Combination Products and Convergence: An Overview of Clinical Benefits, Regulatory Issues & Manufacturing Challenges Apr 21, 2014 Online Instruction Global Online
Social and Collaborative Tools in Regulatory Intelligence Apr 21, 2014 Online Instruction Global Online
Certificates of Pharmaceutical Products for Regulatory Submissions Apr 21, 2014 Online Instruction Global Online
FDASIA Year in Review Apr 21, 2014 Online Instruction Global Online
The Case of the New England Compounding Center: Learning from the Tragedy Apr 21, 2014 Online Instruction Global Online
The Future of Personalized Medicine and Companion Diagnostics Apr 21, 2014 Online Instruction Global Online
Two-part Webinar Series: Impact of the New European Pharmacovigilance Legislation and Important Updates Apr 21, 2014 Online Instruction Global Online
FDA and the Freedom of Information Act: The Unredacted Story Apr 21, 2014 Online Instruction Global Online
The Current State of Quality Oversight (QO) in the Pharmaceutical Industry Apr 21, 2014 Online Instruction Global Online
Combination Product Premarket Considerations Apr 21, 2014 Online Instruction Global Online
Utilizing the 505(b)(2) Pathway to Streamline and Accelerate a Drug Development Plan Apr 21, 2014 Online Instruction Global Online
Electronic Submissions: The Next Era of Electronic Submissions Apr 22, 2014 IACET In-Person Instruction North America Horsham, PA, United States
A Model of Patient, Payer, and Product Developer Collaboration to Support Innovating for Value - CANCELLED Apr 22, 2014 Meetings North America Washington, DC, United States
Strategies for Successfully Introducing REMS to Your Organization: From Development and Implementation to Internal and External Evaluation Apr 23, 2014 IACET Online Instruction Global Online
Key Considerations for the Development and Marketing of Biosimilar Products Apr 24, 2014 IACET In-Person Instruction North America Horsham, PA, United States
Good Pharmacovigilance Practice: How Good has it Proven to be for Industry? Apr 29, 2014 IACET Online Instruction Global Online
Basics of the IND Apr 29, 2014 IACET Online Instruction Global Online
Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies May 01, 2014 IACET Online Instruction Global Online
Global Considerations for Regulatory Strategy Development May 05, 2014 IACET In-Person Instruction North America Horsham, PA, United States
How to Prepare for a Safety Inspection May 06, 2014 IACET Online Instruction Global Online
Drug-Induced Injury of Liver, Heart, Kidney, and Skin: Employing Recent Advances to Improve Patient Safety and Speed Up the Pipeline May 07, 2014 ACPE, CME, IACET Meetings North America North Bethesda, MD, United States
Oversight of Clinical Monitoring: Trends and Strategies May 13, 2014 IACET Online Instruction Global Online
Generic Drug Labeling Proposed Rule and Safety Updates May 15, 2014 Online Instruction Global Online
Complimentary DIA/Covance Webinar - Risk-Based Monitoring: Regulatory Expectation and Operational Application May 15, 2014 Online Instruction Global Online
Big Data: Impact of Health Care Reform on Collaborations and Strategies May 19, 2014 IACET Online Instruction Global Online
Biostatistics and FDA Regulation: The Convergence of Science and Law May 20, 2014 Meetings North America Cambridge, MA, United States
Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework, US May 20, 2014 ACPE, IACET Online Instruction Global Online
Basics of the NDA May 20, 2014 IACET Online Instruction Global Online
Pharmacovigilance and Risk Management: Patient Perspective May 22, 2014 Online Instruction Global Online
China Update: Regulatory Changes and Implications May 28, 2014 Online Instruction Global Online
Complimentary DIA/Optum Webinar: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs May 28, 2014 Online Instruction Global Online
Preparing for a Clinical Trial Budget Jun 03, 2014 IACET, PMI Online Instruction Global Online
Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Jun 05, 2014 IACET Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Jun 10, 2014 ACPE, IACET Online Instruction Global Online
Supplements and Other Changes to an Approved Application Jun 10, 2014 IACET Online Instruction Global Online
#20: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
#21: The Sunshine Act: Understanding the Essentials of Compliance Jun 15, 2014 CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#22: Preparing for a US FDA Advisory Committee Meeting Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
#23: Leadership: How to Organize and Lead People in Group Work Jun 15, 2014 IACET, PMI In-Person Instruction North America San Diego, CA, United States
#24: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
DIA 2014 50th Annual Meeting 'Celebrate the Past - Invent the Future' Jun 15, 2014 Meetings North America San Diego, CA, United States
#40: Analysis of Safety Data from Clinical Trials Jun 15, 2014 ACPE, CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#41: Quality Oversight of CROs-Clinical Vendors Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
#42: Regulatory Affairs for Biologics Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
#43: Clinical Statistics for Nonstatisticians Jun 15, 2014 ACPE, CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#44: Quality by Design: From Theory to Practice Jun 15, 2014 CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#45: Risk Management Plan Jun 15, 2014 ACPE, CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#46: The Good Pharmacovigilance Practices In The EU: Lessons Learned and Frequently Asked Implementation Questions Jun 15, 2014 CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#30: Influencing Culture, Avoiding Bureaucracy, and Encouraging Innovation Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
#31: Large-Scale Regulatory Functional Outsourcing: Emerging Trends, Challenges and Decision Criteria Jun 15, 2014 IACET In-Person Instruction North America San Diego, CA, United States
#32: Pharmacogenomics and Companion Diagnostics: The Future of Clinical Trials, New Product Development and the Practice of Medicine Jun 15, 2014 ACPE, CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#33: Bayesian Evidence Synthesis and Network Meta-analysis Jun 15, 2014 CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#34: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports Jun 15, 2014 ACPE, CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
#35: Understanding Translational Medicine: Benefits and Innovative Approaches Jun 15, 2014 CME, IACET, RN In-Person Instruction North America San Diego, CA, United States
Variations in the European Union: CMC/Quality Changes Jun 26, 2014 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 4: Dosing in Children Jul 08, 2014 ACPE, IACET Online Instruction Global Online
Advanced Clinical Statistics for Nonstatisticians Jul 15, 2014 ACPE, IACET Online Instruction Global Online
Adverse Event Reporting Requirements: IND and Postmarketing Jul 22, 2014 IACET Online Instruction Global Online
Planning and Managing Your Projects Jul 29, 2014 IACET, PMI Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Aug 12, 2014 ACPE, IACET Online Instruction Global Online
Team Building and Development Aug 13, 2014 IACET, PMI Online Instruction Global Online
Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Aug 18, 2014 ACPE, IACET In-Person Instruction North America
Regulatory Affairs: The IND, NDA, and Postmarketing Aug 18, 2014 IACET In-Person Instruction North America Boston, MA, United States
Clinical Project Management Aug 18, 2014 IACET, PMI In-Person Instruction North America Boston, MA, United States
New Drug Product Development and Life Cycle Management Aug 18, 2014 IACET, PMI In-Person Instruction North America Boston, MA, United States
European Regulatory Affairs: Keeping Your Finger on the Pulse of Marketing Authorizations Aug 18, 2014 IACET In-Person Instruction North America Boston, MA, United States
Project Risk Management Aug 20, 2014 IACET, PMI In-Person Instruction North America Boston, MA, United States
Overview of Drug Development Sep 08, 2014 IACET, PMI In-Person Instruction North America Horsham, PA, United States
Key Considerations for the Development and Marketing of Biosimilar Products Sep 09, 2014 IACET In-Person Instruction North America Horsham, PA, United States
Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Sep 09, 2014 ACPE, IACET Online Instruction Global Online
Art of Writing a Clinical Overview Sep 09, 2014 IACET Online Instruction Global Online
Development of a Clinical Study Report Sep 15, 2014 IACET In-Person Instruction North America Rockville, MD, United States
Clinical Statistics for Nonstatisticians Sep 15, 2014 ACPE, IACET In-Person Instruction North America Rockville, MD, United States
EDM and ERS 2014 Sep 22, 2014 Meetings North America
Strategies for Good Clinical Practice Audits Sep 23, 2014 IACET, RN Online Instruction Global Online
Introduction to Signal Detection and Data Mining Sep 29, 2014 IACET Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Oct 14, 2014 ACPE, IACET Online Instruction Global Online
Regulatory Affairs for Biologics Oct 19, 2014 IACET In-Person Instruction North America Irvine, CA, United States
Postmarketing Drug Safety and Pharmacovigilance Oct 20, 2014 ACPE, IACET In-Person Instruction North America Horsham, PA, United States
DIA’s Annual Canadian Meeting: Thinking Globally, Acting Locally for The Well-Being of the Patient Oct 28, 2014 Meetings North America Ottawa, ON, Canada
Negotiation and Influence Oct 30, 2014 IACET, PMI Online Instruction Global Online
Navigating Chemistry, Manufacturing & Controls Through the Drug Development Process Nov 03, 2014 IACET In-Person Instruction North America Horsham, PA, United States
Pediatric Research Conference 2014: Transforming the Pediatric Research Landscape through Innovation and Forward Thinking Nov 06, 2014 Meetings North America
Electronic Submissions: The Next Era of Electronic Submissions Nov 09, 2014 IACET In-Person Instruction North America Bethesda, MD, United States
Regulatory Affairs: The IND, NDA, and Postmarketing Nov 10, 2014 IACET In-Person Instruction North America Bethesda, MD, United States
The Leadership Experience Nov 10, 2014 IACET, PMI In-Person Instruction North America Bethesda, MD, United States
Risk Management and Safety Communication Strategies Nov 10, 2014 ACPE, IACET In-Person Instruction North America Bethesda, MD, United States